Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Covetrus, Inc. stock logo
CVET
Covetrus
$20.99
$20.97
$13.39
$21.20
$2.94B1.511.34 million shs3 shs
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
$4.00
$4.00
$2.43
$14.46
$304M0.82545,194 shs744,968 shs
PetMed Express, Inc. stock logo
PETS
PetMed Express
$3.35
-1.8%
$3.63
$2.90
$6.85
$69.09M0.78228,660 shs10,271 shs
Rite Aid Co. stock logo
RAD
Rite Aid
$0.80
$0.38
$7.37
$34.71M1.254.16 million shs5,426 shs
111, Inc. Sponsored ADR stock logo
YI
111
$7.66
+1.7%
$7.84
$4.15
$12.90
$66.14M0.4425,078 shs462 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Covetrus, Inc. stock logo
CVET
Covetrus
0.00%0.00%0.00%0.00%0.00%
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
0.00%0.00%0.00%0.00%0.00%
PetMed Express, Inc. stock logo
PETS
PetMed Express
-0.58%-1.16%-18.62%+12.17%-7.08%
Rite Aid Co. stock logo
RAD
Rite Aid
0.00%0.00%0.00%0.00%0.00%
111, Inc. Sponsored ADR stock logo
YI
111
+0.97%+4.30%-4.10%+12.98%-26.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Covetrus, Inc. stock logo
CVET
Covetrus
N/AN/AN/AN/AN/AN/AN/AN/A
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
N/AN/AN/AN/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.0639 of 5 stars
0.83.00.00.02.33.30.6
Rite Aid Co. stock logo
RAD
Rite Aid
0.069 of 5 stars
0.00.00.01.90.00.00.6
111, Inc. Sponsored ADR stock logo
YI
111
0.8328 of 5 stars
0.05.00.00.01.01.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Covetrus, Inc. stock logo
CVET
Covetrus
0.00
N/AN/AN/A
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
0.00
N/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.50
Reduce$3.35N/A
Rite Aid Co. stock logo
RAD
Rite Aid
0.00
N/AN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CVET, RAD, PETS, YI, and DPLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
6/11/2025
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (D-) ➝ Sell (E+)
5/24/2025
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (D-)
5/10/2025
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
4/24/2025
111, Inc. Sponsored ADR stock logo
YI
111
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
4/17/2025
PetMed Express, Inc. stock logo
PETS
PetMed Express
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$3.50 ➝ $3.20
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Covetrus, Inc. stock logo
CVET
Covetrus
$4.58B0.64$2.19 per share9.59$10.97 per share1.91
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
$5.49B0.06$4.60 per share0.87$6.24 per share0.64
PetMed Express, Inc. stock logo
PETS
PetMed Express
$247.01M0.28$0.02 per share150.50$4.57 per share0.73
Rite Aid Co. stock logo
RAD
Rite Aid
$24.09B0.00N/A0.36($11.35) per share0.00
111, Inc. Sponsored ADR stock logo
YI
111
$1.97B0.03N/AN/A($10.43) per share-0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Covetrus, Inc. stock logo
CVET
Covetrus
-$54M-$0.10N/A20.78N/A-0.28%6.83%3.01%N/A
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
-$302.27M$0.20N/AN/AN/A-12.47%-12.15%-3.05%N/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$7.46M$0.01334.83111.67N/A0.14%0.37%0.23%8/5/2025 (Estimated)
Rite Aid Co. stock logo
RAD
Rite Aid
-$749.94M-$17.25N/AN/AN/A-3.99%N/A-1.90%N/A
111, Inc. Sponsored ADR stock logo
YI
111
-$1.42M-$0.64N/AN/A-0.48%N/A-2.45%8/27/2025 (Estimated)

Latest CVET, RAD, PETS, YI, and DPLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/19/2025Q1 2025
111, Inc. Sponsored ADR stock logo
YI
111
N/A-$0.20N/A-$0.20N/A$486.35 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Covetrus, Inc. stock logo
CVET
Covetrus
N/AN/AN/AN/AN/A
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
N/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$0.9026.87%N/A9,000.00%N/A
Rite Aid Co. stock logo
RAD
Rite Aid
N/AN/AN/AN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Covetrus, Inc. stock logo
CVET
Covetrus
0.65
1.88
1.08
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
0.18
0.55
0.36
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
1.43
1.18
Rite Aid Co. stock logo
RAD
Rite Aid
N/A
1.32
0.61
111, Inc. Sponsored ADR stock logo
YI
111
N/A
1.14
0.53

Institutional Ownership

CompanyInstitutional Ownership
Covetrus, Inc. stock logo
CVET
Covetrus
92.20%
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
83.92%
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%
Rite Aid Co. stock logo
RAD
Rite Aid
34.47%
111, Inc. Sponsored ADR stock logo
YI
111
21.32%

Insider Ownership

CompanyInsider Ownership
Covetrus, Inc. stock logo
CVET
Covetrus
0.40%
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
24.10%
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.10%
Rite Aid Co. stock logo
RAD
Rite Aid
1.58%
111, Inc. Sponsored ADR stock logo
YI
111
43.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Covetrus, Inc. stock logo
CVET
Covetrus
5,710140.12 million139.56 millionNot Optionable
Diplomat Pharmacy Inc stock logo
DPLO
Diplomat Pharmacy
2,33576.00 millionN/AOptionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
21020.66 million20.43 millionOptionable
Rite Aid Co. stock logo
RAD
Rite Aid
47,00056.70 million55.80 millionOptionable
111, Inc. Sponsored ADR stock logo
YI
111
1,2388.64 million4.85 millionOptionable

Recent News About These Companies

111 (YI) vs. Its Peers Critical Analysis
F-111 Walkaround (HARS Museum)
The F-111 Aardvark Summed Up in 4 Words
111 (NASDAQ:YI) Posts Earnings Results
Game Recap: Thunder 111, Pacers 104
Thunder evens NBA Finals at 2-2 with 111-104 win

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Covetrus stock logo

Covetrus NASDAQ:CVET

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Diplomat Pharmacy stock logo

Diplomat Pharmacy NYSE:DPLO

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company operates through Specialty and PBM (pharmacy benefit management) segment. It provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company primarily focuses on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. It also offers PBM services, including electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, drug review and analysis, consulting services, data access, and reporting, information analysis, and preferred drug management programs to managed care organizations, self-insured employer groups, unions, and third-party healthcare plan administrators and worker's compensation payers. The company was founded in 1975 and is headquartered in Flint, Michigan.

PetMed Express stock logo

PetMed Express NASDAQ:PETS

$3.35 -0.06 (-1.76%)
As of 10:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Rite Aid stock logo

Rite Aid NYSE:RAD

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

111 stock logo

111 NASDAQ:YI

$7.66 +0.13 (+1.66%)
As of 10:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.